Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
We already have one thats on the market, tirzepatide (Mounjaro), which is activating both the GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, and at least in terms of weight loss, appears to be somewhat more effective than semaglutide (Ozempic), says Professor Cummings
The trade is explicit: the patient gives up the possibility of insurance subsidy, and in exchange gets pricing certainty, no prior-authorization gauntlet, and continuity that does not reset every time an employer renegotiates its formulary
Ideal candidates include those with substantial weight to lose who have not achieved results with diet and exercise alone
This anti-inflammatory profile would not be expected to worsen statin myopathy
